摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-Methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carbonitrile | 849663-46-3

中文名称
——
中文别名
——
英文名称
1-(4-Methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carbonitrile
英文别名
——
1-(4-Methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carbonitrile化学式
CAS
849663-46-3
化学式
C16H13N5O
mdl
——
分子量
291.312
InChiKey
UPQHENYOXGQQBL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.24
  • 重原子数:
    22.0
  • 可旋转键数:
    2.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    79.52
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    1-(4-Methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carbonitrile盐酸羟胺potassium carbonate 作用下, 以 乙醇 为溶剂, 反应 4.0h, 以76%的产率得到N-Hydroxy-1-(4-methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carboxamidine
    参考文献:
    名称:
    Benzodipyrazoles: a new class of potent CDK2 inhibitors
    摘要:
    The synthesis and the preliminary expansion of this new class of CDK2 inhibitors are presented. The synthesis was accomplished using a solution-phase protocol amenable to rapid parallel expansion and suitable to be scaled-up in view of possible lead development. Following a medicinal chemistry program aimed at improving cell permeability and selectivity, a series of compounds with nanomolar activity in the biochemical assay and able to efficiently inhibit tumor cell proliferation has been obtained.
    DOI:
    10.1016/j.bmcl.2005.01.023
  • 作为产物:
    描述:
    1-(4-Methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carboxylic acid amide吡啶三氟乙酸酐 作用下, 反应 0.5h, 以85%的产率得到1-(4-Methoxy-phenyl)-1,4,5,6-tetrahydro-benzo[1,2-c;3,4-c']dipyrazole-3-carbonitrile
    参考文献:
    名称:
    Benzodipyrazoles: a new class of potent CDK2 inhibitors
    摘要:
    The synthesis and the preliminary expansion of this new class of CDK2 inhibitors are presented. The synthesis was accomplished using a solution-phase protocol amenable to rapid parallel expansion and suitable to be scaled-up in view of possible lead development. Following a medicinal chemistry program aimed at improving cell permeability and selectivity, a series of compounds with nanomolar activity in the biochemical assay and able to efficiently inhibit tumor cell proliferation has been obtained.
    DOI:
    10.1016/j.bmcl.2005.01.023
点击查看最新优质反应信息